Chenguang Medical released the investor relations activity record. The company's business with Royal Philips is proceeding as normal. In the first half of 2024, the company's overseas revenue increased by 114.01% year-on-year, mainly contributed by Royal Philips. In addition, the maintenance business with Royal Philips also began to recover in the second half of this year.
辰光医疗：和飞利浦业务在正常进行
Chenguang Medical: The business with Royal Philips is proceeding as usual.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.